Insiders trading at Oxford Immunotec Global PLC
Over the last 11 years, insiders at Oxford Immunotec Global PLC have traded over $13,598,906 worth of Oxford Immunotec Global PLC stock and bought 47,600 units worth $549,576 . The most active insiders traders include James R Tobin, Peter Wrighton Smith a Ronald Asbury Andrews. On average, Oxford Immunotec Global PLC executives and independent directors trade stock every 36 days with the average trade being worth of $536,006. The most recent stock trade was executed by Patrick J Balthrop on 20 May 2020, trading 4,000 units of OXFD stock currently worth $49,920.
What does Oxford Immunotec Global PLC's logo look like?
Oxford Immunotec Global PLC executives and stock owners
Oxford Immunotec Global PLC executives and other stock owners filed with the SEC include:
-
Peter Wrighton-Smith,
Chief Executive Officer, Director -
Matthew McLaughlin,
Chief Financial Officer -
Richard Sandberg,
Independent Director -
Patrick Balthrop,
Independent Chairman of the Board -
Herman Rosenman,
Independent Director -
James Tobin,
Independent Director -
Patricia Randall,
Independent Director -
Andrew Walton,
Independent Director -
Mark Klausner,
Independent Director -
Ronald Andrews,
Independent Director -
Janet Kidd,
General Counsel, Company Secretary -
Herm Rosenman,
-
Richard M. Altieri,
Chief Financial Officer -
Peter Edwardson,
Chief Operations Officer -
Stephen L Spotts,
Director -
Jeff R. Schroeder,
Chief Commercial Officer -
Richard Wenstrup,
Chief Medical Officer -
Stefan C Linn,
Chief Operating Officer -
Elizabeth M Keiley,
VP & General Counsel -
Lifesciences I, L.P.Clarus ...,
-
Leaf Ventures Ii, L.P.New L...,